| # | Drug | Count |
|---|---|---|
| 0 | IPILIMUMAB | 37 |
| 1 | NIVOLUMAB | 21 |
| 2 | OCTREOTIDE ACETATE | 19 |
| 3 | PEGVISOMANT | 9 |
| 4 | CABERGOLINE | 8 |
| 5 | METFORMIN | 8 |
| 6 | METFORMIN ER 500 MG | 8 |
| 7 | METFORMIN ER 750 MG | 8 |
| 8 | PREDNISONE | 8 |
| 9 | INTERFERON BETA-1A | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGVISOMANT | 9 | 0.0022 |
| 1 | CABERGOLINE | 8 | 0.0016 |
| 2 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 3 | LAZERTINIB | 1 | 0.0012 |
| 4 | IPILIMUMAB | 37 | 0.0008 |
| 5 | SENNA LAXATIVE | 1 | 0.0008 |
| 6 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 7 | CEFACLOR | 1 | 0.0006 |
| 8 | OCTREOTIDE ACETATE | 19 | 0.0006 |
| 9 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 8 | 0.0016 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 37 | 0.0008 |
| 2 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 30 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 5 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Vitamin D3 Analog [EPC] | 2 | 0.0001 |
| 9 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |